High-dose preoperative glucocorticoid for prevention of emergence and postoperative delirium in liver resection: A double-blinded randomized clinical trial substudy

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

High-dose preoperative glucocorticoid for prevention of emergence and postoperative delirium in liver resection : A double-blinded randomized clinical trial substudy. / Awada, Hussein Nasser; Steinthorsdottir, Kristin Julia; Schultz, Nicolai A.; Hillingsø, Jens G.; Larsen, Peter Nørgaard; Jans, Øivind; Kehlet, Henrik; Aasvang, Eske Kvanner.

In: Acta Anaesthesiologica Scandinavica, Vol. 66, No. 6, 2022, p. 696-703.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Awada, HN, Steinthorsdottir, KJ, Schultz, NA, Hillingsø, JG, Larsen, PN, Jans, Ø, Kehlet, H & Aasvang, EK 2022, 'High-dose preoperative glucocorticoid for prevention of emergence and postoperative delirium in liver resection: A double-blinded randomized clinical trial substudy', Acta Anaesthesiologica Scandinavica, vol. 66, no. 6, pp. 696-703. https://doi.org/10.1111/aas.14057

APA

Awada, H. N., Steinthorsdottir, K. J., Schultz, N. A., Hillingsø, J. G., Larsen, P. N., Jans, Ø., Kehlet, H., & Aasvang, E. K. (2022). High-dose preoperative glucocorticoid for prevention of emergence and postoperative delirium in liver resection: A double-blinded randomized clinical trial substudy. Acta Anaesthesiologica Scandinavica, 66(6), 696-703. https://doi.org/10.1111/aas.14057

Vancouver

Awada HN, Steinthorsdottir KJ, Schultz NA, Hillingsø JG, Larsen PN, Jans Ø et al. High-dose preoperative glucocorticoid for prevention of emergence and postoperative delirium in liver resection: A double-blinded randomized clinical trial substudy. Acta Anaesthesiologica Scandinavica. 2022;66(6):696-703. https://doi.org/10.1111/aas.14057

Author

Awada, Hussein Nasser ; Steinthorsdottir, Kristin Julia ; Schultz, Nicolai A. ; Hillingsø, Jens G. ; Larsen, Peter Nørgaard ; Jans, Øivind ; Kehlet, Henrik ; Aasvang, Eske Kvanner. / High-dose preoperative glucocorticoid for prevention of emergence and postoperative delirium in liver resection : A double-blinded randomized clinical trial substudy. In: Acta Anaesthesiologica Scandinavica. 2022 ; Vol. 66, No. 6. pp. 696-703.

Bibtex

@article{196af19f2483424c9a1ebbae3fb1ce2d,
title = "High-dose preoperative glucocorticoid for prevention of emergence and postoperative delirium in liver resection: A double-blinded randomized clinical trial substudy",
abstract = "Background: Emergence delirium (ED) and postoperative delirium (POD) are associated with increased morbidity and mortality and occur in up to one-third of patients undergoing major non-cardiac surgery, where the underlying pathogenesis is multifactorial, including increased inflammation. We aimed to assess the effect of pre-operative high- versus low-dose glucocorticoid on the occurrence of ED and POD. Methods: This was a substudy from a randomized, double-blinded clinical trial. Patients ≥18 years, undergoing open liver resection were randomized 1:1 to high-dose (HD, 10 mg/kg methylprednisolone) or low-dose (LD, 8 mg dexamethasone) glucocorticoid and assessed for ED and POD for a maximum of 4 days during hospitalization. The 3-min Diagnostic Interview for CAM-defined delirium (3D-CAM) was used for assessment, 15 and 90 min after arrival in the post-anesthesia care unit (PACU), and subsequently once daily in the ward. Results: Fifty-three patients were included in this secondary substudy (26 HD-group and 27 LD-group). ED occurred in n = 5 HD versus n = 6 LD patients 15 min after PACU arrival. At 90 min after PACU arrival, 4 patients had ED, all from LD-group, and resulted in significantly longer PACU admission, 273 versus 178 min in ED versus Non-ED patients. During the first 4 days in the ward, n = 5 patients had at least one occurrence of POD, all from LD-group. Conclusions: The primary finding of the current substudy was a lower occurrence of ED/POD in the PACU 90 min after arrival and during the first four postoperative days in patients receiving high-dose glucocorticoid compared with patients receiving low-dose glucocorticoid. The two study groups were not evenly balanced concerning known explanatory factors, i.e., age and size of surgery, which calls for larger studies to elucidate the matter.",
keywords = "emergence, liver resection, postoperative delirium, preoperative glucocorticoid",
author = "Awada, {Hussein Nasser} and Steinthorsdottir, {Kristin Julia} and Schultz, {Nicolai A.} and Hillings{\o}, {Jens G.} and Larsen, {Peter N{\o}rgaard} and {\O}ivind Jans and Henrik Kehlet and Aasvang, {Eske Kvanner}",
note = "Publisher Copyright: {\textcopyright} 2022 The Authors. Acta Anaesthesiologica Scandinavica published by John Wiley & Sons Ltd on behalf of Acta Anaesthesiologica Scandinavica Foundation.",
year = "2022",
doi = "10.1111/aas.14057",
language = "English",
volume = "66",
pages = "696--703",
journal = "Acta Anaesthesiologica Scandinavica",
issn = "0001-5172",
publisher = "Wiley-Blackwell",
number = "6",

}

RIS

TY - JOUR

T1 - High-dose preoperative glucocorticoid for prevention of emergence and postoperative delirium in liver resection

T2 - A double-blinded randomized clinical trial substudy

AU - Awada, Hussein Nasser

AU - Steinthorsdottir, Kristin Julia

AU - Schultz, Nicolai A.

AU - Hillingsø, Jens G.

AU - Larsen, Peter Nørgaard

AU - Jans, Øivind

AU - Kehlet, Henrik

AU - Aasvang, Eske Kvanner

N1 - Publisher Copyright: © 2022 The Authors. Acta Anaesthesiologica Scandinavica published by John Wiley & Sons Ltd on behalf of Acta Anaesthesiologica Scandinavica Foundation.

PY - 2022

Y1 - 2022

N2 - Background: Emergence delirium (ED) and postoperative delirium (POD) are associated with increased morbidity and mortality and occur in up to one-third of patients undergoing major non-cardiac surgery, where the underlying pathogenesis is multifactorial, including increased inflammation. We aimed to assess the effect of pre-operative high- versus low-dose glucocorticoid on the occurrence of ED and POD. Methods: This was a substudy from a randomized, double-blinded clinical trial. Patients ≥18 years, undergoing open liver resection were randomized 1:1 to high-dose (HD, 10 mg/kg methylprednisolone) or low-dose (LD, 8 mg dexamethasone) glucocorticoid and assessed for ED and POD for a maximum of 4 days during hospitalization. The 3-min Diagnostic Interview for CAM-defined delirium (3D-CAM) was used for assessment, 15 and 90 min after arrival in the post-anesthesia care unit (PACU), and subsequently once daily in the ward. Results: Fifty-three patients were included in this secondary substudy (26 HD-group and 27 LD-group). ED occurred in n = 5 HD versus n = 6 LD patients 15 min after PACU arrival. At 90 min after PACU arrival, 4 patients had ED, all from LD-group, and resulted in significantly longer PACU admission, 273 versus 178 min in ED versus Non-ED patients. During the first 4 days in the ward, n = 5 patients had at least one occurrence of POD, all from LD-group. Conclusions: The primary finding of the current substudy was a lower occurrence of ED/POD in the PACU 90 min after arrival and during the first four postoperative days in patients receiving high-dose glucocorticoid compared with patients receiving low-dose glucocorticoid. The two study groups were not evenly balanced concerning known explanatory factors, i.e., age and size of surgery, which calls for larger studies to elucidate the matter.

AB - Background: Emergence delirium (ED) and postoperative delirium (POD) are associated with increased morbidity and mortality and occur in up to one-third of patients undergoing major non-cardiac surgery, where the underlying pathogenesis is multifactorial, including increased inflammation. We aimed to assess the effect of pre-operative high- versus low-dose glucocorticoid on the occurrence of ED and POD. Methods: This was a substudy from a randomized, double-blinded clinical trial. Patients ≥18 years, undergoing open liver resection were randomized 1:1 to high-dose (HD, 10 mg/kg methylprednisolone) or low-dose (LD, 8 mg dexamethasone) glucocorticoid and assessed for ED and POD for a maximum of 4 days during hospitalization. The 3-min Diagnostic Interview for CAM-defined delirium (3D-CAM) was used for assessment, 15 and 90 min after arrival in the post-anesthesia care unit (PACU), and subsequently once daily in the ward. Results: Fifty-three patients were included in this secondary substudy (26 HD-group and 27 LD-group). ED occurred in n = 5 HD versus n = 6 LD patients 15 min after PACU arrival. At 90 min after PACU arrival, 4 patients had ED, all from LD-group, and resulted in significantly longer PACU admission, 273 versus 178 min in ED versus Non-ED patients. During the first 4 days in the ward, n = 5 patients had at least one occurrence of POD, all from LD-group. Conclusions: The primary finding of the current substudy was a lower occurrence of ED/POD in the PACU 90 min after arrival and during the first four postoperative days in patients receiving high-dose glucocorticoid compared with patients receiving low-dose glucocorticoid. The two study groups were not evenly balanced concerning known explanatory factors, i.e., age and size of surgery, which calls for larger studies to elucidate the matter.

KW - emergence

KW - liver resection

KW - postoperative delirium

KW - preoperative glucocorticoid

U2 - 10.1111/aas.14057

DO - 10.1111/aas.14057

M3 - Journal article

C2 - 35325467

AN - SCOPUS:85127737440

VL - 66

SP - 696

EP - 703

JO - Acta Anaesthesiologica Scandinavica

JF - Acta Anaesthesiologica Scandinavica

SN - 0001-5172

IS - 6

ER -

ID: 312625150